Entacapone Treatment Modulates Hippocampal Proteins Related to Synaptic Vehicle Trafficking

Entacapone, a reversible inhibitor of catechol-O-methyl transferase, is used for patients in Parkinson’s disease because it increases the bioavailability and effectiveness of levodopa. In the present study, we observed that entacapone increases novel object recognition and neuroblasts in the hippoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Dae Young, Jung, Hyo Young, Kim, Woosuk, Hahn, Kyu Ri, Kwon, Hyun Jung, Nam, Sung Min, Chung, Jin Young, Yoon, Yeo Sung, Kim, Dae Won, Hwang, In Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765944/
https://www.ncbi.nlm.nih.gov/pubmed/33352833
http://dx.doi.org/10.3390/cells9122712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765944/
https://www.ncbi.nlm.nih.gov/pubmed/33352833
http://dx.doi.org/10.3390/cells9122712

Ejemplares similares